Parker Waichman LLP

Multaq Faces FDA Scrutiny As Safety Concerns Mount

The U.S. Food & Drug Administration (FDA) said yesterday that it is continuing to review the safety of Multaq, as more and more specialists report they are no longer prescribing the drug. Multaq has been linked to a number of serious side effects, including liver failure and worsening heart problems. As we’ve reported previously, Multaq […]

The U.S. Food & Drug Administration (FDA) said yesterday that it is continuing to review the safety of <"https://www.yourlawyer.com/topics/overview/multaq-dronedarone-liver-damage-failure-lawsuit-lawyer-attorney">Multaq, as more and more specialists report they are no longer prescribing the drug. Multaq has been linked to a number of serious side effects, including liver failure and worsening heart problems.

As we’ve reported previously, Multaq was approved to treat temporary atrial fibrillation. It was touted as a safer alternative to amiodarone, a generic medicine associated with serious liver and lung risks. Approximately 400,000 patients worldwide have been treated with Multaq since it came on the market in 2009.

According to a report in The Wall Street Journal, Multaq was associated with a higher death rate even before it was approved in 2009. It already carries a boxed warning saying that the drug more than doubled the risk of death for the sickest heart-failure patients in one study. Before it was cleared by the FDA, reviewers “questioned the results of a second trial suggesting that the drug could ward off hospitalization, saying the standards for hospitalization can vary.” The reviewers also concluded Multaq “presents a problem that the label alone may not be able to cover,” the Journal said. Still, an FDA advisory panel backed the drug, finding it could help some patients. However, according to a transcript of the advisory panel meeting reviewed by the Journal, the members worried whether it was possible to distinguish patients who died from others who might benefit from Multaq.

Since then, concerns about the safety of Multaq have only grown. In January, the FDA announced that the U.S. label for Multaq had been updated, following reports of liver damage, including severe liver failure, associated with the drug. Then in July, the FDA announced that it was reviewing information from a clinical trial that was halted after moderately sick patients with permanent atrial fibrillation treated with Multaq experienced double the rate of death and stroke.

There are also questions about Multaq’s effectiveness. Last year, for example, cardiologists from the Cedars-Sinai Medical Center said last year that generic alternatives work better than Multaq and that the drug should be considered only when other alternatives don’t work.

Now, according to The Wall Street Journal, some doctors said that, because of published studies and their own clinical experience with the drug, they no longer recommend Multaq. These doctors include Sanjay Kaul, a cardiologist at Cedars-Sinai Medical Center in Los Angeles who was one of the FDA advisory panel that recommended the agency approve Multaq in 2009. “It seems like it’s not even safe in intermediate-risk patients,” Kaul told the Journal.

A cardiologist from Louisville, Kentucky, told the Journal that many doctors have similar concerns about Multaq. “I’m surprised that the drug has persisted,” John Mandrola ” I don’t know any of my colleagues who would start a patient out on Multaq. It just doesn’t work.”

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Great staff extremely helpful and sympathetic to your needs
David Fritzman
5 years ago
5 Star Reviews 150
Roy Cronin is both handsome and charming. He is the greatest computer guy this side of Bill Gates and Steve Jobs.
Roy Cronin
5 years ago
5 Star Reviews 150
Francisco A. Albites Esq. recently represented me in a legal matter. He communicated with me directly. He very skillfully negotiated my case to a successful outcome. Mr. Alibites knowledge of the law and his integrity are a testament to his success as an attorney. I would 100% refer him to friends and family members.
Gary Utech
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038